AWH Aspira Women's Health: Rasio Kapitalisasi Pasar marang Nilai Buku

Simbol resmi perusahaan Aspira Women's Health Inc (AWH)

Due to the humanitarian status of biomedicine, Aspira Women's Health operates within a stable geopolitical environment. Analyzing the company's price-to-book ratio on GURU.Markets, we note that the metric has settled at -0.53. The competitiveness of AWH is based on proprietary oncology diagnostic algorithms, while operational efficiency is achieved through cloud outsourcing of IT infrastructure and user support.

Aspira Women's Health Inc (AWH): Rasio Kapitalisasi marang Nilai Buku saka 04.07.2022 nganti 26.04.2025
Barang utama Aspira Women's Health, Inc.

Aspira Women's Health is scaling the commercial implementation of innovative oncology tests by expanding insurance coverage. This metric compares the current market value of the business with its net book value. This ratio determines the extent to which shares are overvalued relative to the company's tangible assets. The fundamental value of assets serves as a defensive barrier during market volatility. The trend of this parameter within the historical relationship between market capitalization and book value allows for an assessment of the investment's margin of safety.

Pesaing utama

A (Agilent Technologies) - Rasio Nilai Pasar marang Nilai Buku|questdiagnostics.com (DGX) - Rasio Kapitalisasi marang Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku ILMN (Illumina)|Koefisien Nilai Pasar marang Nilai Buku Exact Sciences Corp|Rasio Kapitalisasi Pasar marang Nilai Buku PerkinElmer RVTY|Rasio Kapitalisasi marang Nilai Buku Bio-Rad Corp (BIO)|Rasio Kapitalisasi Pasar marang Nilai Buku NNNN (Anbio Biotechnology)|soterahealth.com - Rasio Kapitalisasi Pasar marang Nilai Buku|QuidelOrtho Corporation (QDEL) - Rasio Nilai Pasar marang Nilai Buku|OPK - Rasio Kapitalisasi marang Nilai Buku|CDNA: Rasio Kapitalisasi Pasar marang Nilai Buku|MRVI (Maravai) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Fulgent Genetics, Inc.|Rasio Nilai Pasar marang Nilai Buku fluidigm.com (LAB)|Cytek Biosciences - Rasio Kapitalisasi marang Aset Bersih|Koefisien Nilai Pasar marang Nilai Buku OSUR (OraSure Technologies, Inc.)|Rasio Nilai Pasar marang Nilai Buku XGN|Kapitalisasi Pasar marang Nilai Buku MDxHealth, Inc. MDXH|Rasio Kapitalisasi Pasar marang Nilai Buku LUCD (Lucid Diagnostics Inc.)|PRE: Kapitalisasi Pasar marang Nilai Buku|imdxinc.com - Rasio Nilai Pasar marang Nilai Buku|Trinity Biotech (TRIB) - Kapitalisasi Pasar marang Nilai Buku|PRPH (ProPhase) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku AIMD|CODX (Co-Diagnostics, Inc.) - Rasio Nilai Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku HSCS (heartsciences.com)|Biomerica (BMRA) - Rasio Nilai Pasar marang Nilai Buku|Kapitalisasi Pasar marang Aset Bersih Cardio Diagnostics Holdings Inc. CDIO|Rasio Kapitalisasi Pasar marang Nilai Buku VRAX (Virax Biolabs Group Ltd)|BJDX: Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Accelerate Diagnostics AXDX|CENTOGENE (CNTG) - Nilai Pasar marang Nilai Buku|ENZ (Enzo Biochem Inc.) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku Fresh2 (FRES)|Genetic Technologies (GENE) - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku 23andMe Inc ME|Psychemedics - Rasio Kapitalisasi marang Aset Bersih